Tvardi Therapeutics, Inc. is a clinical-stage biopharmaceutical company focused on the development of novel, oral small molecule therapies targeting STAT3 to treat fibrosis-driven diseases with significant unmet need. The company was founded in 2017 and is headquartered in Sugar Land, TX.
Fundamentals
Mkt Cap
$14.41M
Volume
-
52W High
$7.23
52W Low
$0.93
PE Ratio
-0.37
Avg. Volume
209,381.20
EPS (Annual)
-$3.26
P/B
1.15
Rev/Employee
$0.00
Earnings
Nov 12
43
Bearish Sentiment
How do you feel about TVRD?
PLATINUM_TRADES
$TVRD Very nice so far I sold a little early but some members still in collecting more.. $1.43 Is major resistance on this one 🕜
1
CandleSnipe
$TVRD Travere reported $489M cash and cash equivalents and marketable securities at June 30, 2026...
1
PLATINUM_TRADES
$TVRD I took the tiny profits I can't take a risk in this market.. Will revisit... But I'm gonna stay green no matter how little 🤏